Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
T.J. Liles-Tims and Liza Bowersox explore how professionals can mitigate risk in business valuation and connect within advisor/client relationships.
T.J. Liles-Tims and Liza Bowersox explore how prenuptial agreements can protect individual and business assets through strategic valuation.
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
T.J. Liles-Tims and Liza Bowersox discuss strategies to enhance business value, business risks and the importance of forward-thinking governance.
Shale maturation and technological innovation impact IP valuations, influencing long-term asset value and productivity in the oil and gas industry.
T.J. Liles-Tims and Liza Bowersox discuss the intricacies of business valuation and strategies for reducing conflicts.
Weaver's Jeremy Winkler and Selina McUmber discuss insights and trends from the 2024 NCREIF conference on real estate, valuations and global future-shaping factors.
Join us on-demand for a deep dive conversation into critical tax and valuation considerations for year-end.
Discover how Property Assessed Clean Energy (PACE) financing drives business growth in this episode of Weaver: Beyond the Numbers, Location Cubed.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.
Explore the nuances of valuations for real estate assets, and its cadence, challenges and strategies.